 Your new post is loading...
Your new post is loading...
I am a practicing UK general practitioner and in this article, I take a magnifying glass to quality indicators including access, affordability, healthcare inequalities and population health, staffing and equipment, and patient and provider experience to discuss how we can shape up. Lire l'article complet sur : medcitynews.com
Via Emmanuel Capitaine
|
Scooped by
Lionel Reichardt / le Pharmageek
July 4, 2023 3:14 AM
|
This report from Panda Health predicts that digital health tools used by hospitals to cope with the COVID-19 pandemic will be subject to increased scrutiny and Lire l'article complet sur : www.beckershospitalreview.com
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Santé NTIC
April 25, 2023 4:14 PM
|
journée d'étude sur les libertés numériques en temps de covid-19. technologie, données de santé et droit, organisé par l'oppee, université de bordeaux ... Lire l'article complet sur : univ-droit.fr
Via Doc-Ifsi-Narbonne
|
|
Scooped by
Lionel Reichardt / le Pharmageek
April 5, 2023 7:46 AM
|
Member States of the World Health Organization have agreed to a global process to draft and negotiate a convention, agreement or other international instrument under the Constitution of the World Health Organization to strengthen pandemic prevention, preparedness and response. Lire l'article complet sur : www.who.int
In endothelial dysfunction, the inner lining of blood vessels does not work and can lead to symptoms like chest pain. The condition also contributes to several cardiovascular disorders. Lire l'article complet sur : www.verywellhealth.com
Via CARDIOPREV
|
|
Scooped by
Lionel Reichardt / le Pharmageek
March 12, 2023 10:13 AM
|
Electronically delivered letters highlighting potential cardiovascular benefits of
influenza vaccination or sent again as a reminder significantly increased vaccination
uptake across Denmark. Although the magnitude of effectiveness was modest, the low-touch,
inexpensive, and highly scalable nature of these electronic letters might be informative
for future public health campaigns. Lire l'article complet sur : www.thelancet.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
February 22, 2023 7:09 AM
|
Le 14 février 2023, Nature publie un article annonçant la décision de l’OMS d’arrêter l’enquête sur l’origine du virus SARS-CoV-2. Nous revenons sur l'argumentation de l'OMS, qui affirme poursuivre activement cette recherche. Lire l'article complet sur : www.sciencesetavenir.fr
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 22, 2023 10:25 AM
|
Depuis le 1er janvier 2023 et avec la fin de l’état d’urgence sanitaire, Emergen évolue et adapte sa surveillance pour l’identification des variants émergents sur le territoire. Notre expert, Bruno Coignard Lire l'article complet sur : www.santepubliquefrance.fr
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 13, 2023 4:09 AM
|
Premier site français d'information en continu sur les technologies de l'information et de la communication (TIC, NTIC) dans la santé - TICsante Lire l'article complet sur : www.ticsante.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
December 7, 2022 1:13 AM
|
Le traçage des cas contacts exposés au Covid-19 pourrait avoir coûté plus de 600 millions d'euros depuis le début de l'épidémie, indique la Cour des comptes dans un rapport publié mardi, concluant à « l'efficacité incertaine » du dispositif. Lire l'article complet sur : www.lequotidiendumedecin.fr
|
|
Scooped by
Lionel Reichardt / le Pharmageek
November 13, 2022 8:30 AM
|
Every click you make online counts. It is ridiculously easy to fall down a rabbit hole on any subject. You could accidentally go for hours scrolling through content from cat videos to updates on vaccines. While these may just be displays of innocent scrolling, we could just as easily be feeding our minds with dangerous content difficult to remove from our brains later on. Lire l'article complet sur : dailycampus.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
November 4, 2022 7:07 AM
|
Minority populations disproportionately suffer from the effects of COVID-19, as evidenced
by nearly three times the infection rate and one to two times the death rate among
Black, Indigenous, and Latino people compared with White people.1 Although some assume
that these disparities are rooted in genetic differences between racial or ethnic
groups, they are more likely a result of structural inequalities. Minority groups
tend to live in densely populated areas, have limited access to health care, and have
higher rates of comorbidities, among other factors, that put them at greater risk
for infection. Lire l'article complet sur : www.thelancet.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
October 31, 2022 9:28 AM
|
Our study showed that passively collected sensor data from consenting participants
can provide real-time disease tracking and forecasting. With a growing population
of wearable technology users, these sensor data could be integrated into viral surveillance
programmes. Lire l'article complet sur : www.thelancet.com
|
EN SAVOIR PLUS / https://www.e-cancer.fr/Presse/Dossiers-et-communiques-de-presse/Panorama-des-cancers-en-France-l-Institut-national-du-cancer-publie-l-edition-2023-rassemblant-les-donnees-les-plus-recentesPour la troisième année consécutive, l’Institut publie le « Panorama des cancers en France ». Document de référence sur les données des cancers, l’édition 2023 regroupe en trois chapitres les chiffres essentiels les plus récents.Le premier chapitre, sur les données épidémiologiques générales, présente notamment les projections d’incidence1 2023 et leur évolution depuis 1990. Le deuxième chapitre se concentre plus particulièrement sur les données des cancers les plus fréquents chez la femme et chez l’homme. Enfin, dans le troisième et dernier chapitre, l’Institut national du cancer revient sur la prévention des cancers -poids des facteurs de risques évitables et participation aux dépistages organisés- ainsi que sur les soins et les actions de recherche initiées pour limiter le poids de la maladie dans le quotidien des Français ; une ambition de la Stratégie décennale de lutte contre les cancers. Lire l'article complet sur : pratiquesensante.odoo.com
Via Doc-Ifsi-Narbonne
|
|
Scooped by
Lionel Reichardt / le Pharmageek
May 26, 2023 4:50 AM
|
Cliquez ici pour éditer le contenu Lire l'article complet sur : www.jim.fr
|
|
Scooped by
Lionel Reichardt / le Pharmageek
April 9, 2023 4:42 AM
|
Background: The WEAICOR (Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19) study was a prospective observational study that used continuous monitoring to detect and analyze biometrics. Compliance to wearables was a major challenge when conducting the study and was crucial for the results.
Objective: The aim of this study was to evaluate patients’ compliance to wearable wristbands and determinants of compliance in a prospective COVID-19 cohort.
Methods: The Biostrap (Biostrap USA LLC) wearable device was used to monitor participants’ biometric data. Compliance was calculated by dividing the total number of days in which transmissions were sent by the total number of days spent in the WEAICOR study. Univariate correlation analyses were performed, with compliance and days spent in the study as dependent variables and age, BMI, sex, symptom severity, and the number of complications or comorbidities as independent variables. Multivariate linear regression was then performed, with days spent in the study as a dependent variable, to assess the power of different parameters in determining the number of days patients spent in the study.
Results: A total of 122 patients were included in this study. Patients were on average aged 41.32 years, and 46 (38%) were female. Age was found to correlate with compliance (r=0.23; P=.01). In addition, age (r=0.30; P=.001), BMI (r=0.19; P=.03), and the severity of symptoms (r=0.19; P=.03) were found to correlate with days spent in the WEAICOR study. Per our multivariate analysis, in which days spent in the study was a dependent variable, only increased age was a significant determinant of compliance with wearables (adjusted R2=0.1; β=1.6; P=.01).
Conclusions: Compliance is a major obstacle in remote monitoring studies, and the reasons for a lack of compliance are multifactorial. Patient factors such as age, in addition to environmental factors, can affect compliance to wearables.
Lire l'article complet sur : www.jmir.org
|
|
Scooped by
Lionel Reichardt / le Pharmageek
April 5, 2023 5:49 AM
|
Author summary Capturing food exposure of school children is a challenging task due to recall bias. In this manuscript, we describe a machine-learning-based data-collection tool that can automatically record school children’s exposure to food items, food advertisements and food outlets in their homes, schools and neighborhoods. Our data-collection tool consists of a wearable camera to capture continuous footage of children’s environments during a typical school day, and a series of machine learning models that can extract food-related images from the recorded footage and classify them into images that contain food items consumed by the child wearing the camera, or consumed by others, images that contain food advertisements, and images that contain food outlets. We report on a user-centered design study that assessed the acceptability of using wearable cameras to capture food exposure among school children in two urban Arab centers, namely Greater Beirut in Lebanon and Greater Tunis in Tunisia. We then describe how we trained our various machine learning models to capture food exposure among school children and categorize such food exposure into a predefined typology. Finally, we also report on the results of deploying our data-collection tool in a real-world case study in Tunisia. Lire l'article complet sur : journals.plos.org
|
|
Scooped by
Lionel Reichardt / le Pharmageek
April 3, 2023 5:55 AM
|
Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures
and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies.
Such assessments can inform public health policies and contribute to evidence-based
choices of NPIs during subsequent waves or future epidemics. However, methodological
issues and no standardised assessment practices have restricted the practical value
of the existing evidence. Here, we present and discuss lessons learned from the COVID-19
pandemic and make recommendations for standardising and improving assessment, data
collection, and modelling. Lire l'article complet sur : www.thelancet.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
March 5, 2023 5:43 AM
|
Obepi-Roche 2020 by the “Ligue Contre l’Obésité” (League Against Obesity) estimated overweight and obesity prevalence in France. The adopted methodology was chosen to be as similar as possible to that of a series of quota-based surveys conducted every three years from 1997 to 2012 (Obepi-Roche studies). The 2020 survey was conducted online from 24th September to 5th October 2020 by the Odoxa polling institute on a sample of metropolitan French subjects aged 18 years or over. Participants (n = 9598) self-measured their height and weight according to detailed instructions. Prevalence estimates were produced for all categories of body mass index. The prevalence of excess weight was 47.3% (17.0% of subjects with obesity), with higher values in the north and east of France. When comparing these 2020 estimates to previous Obepi-Roche estimates in order to visualize trends since 1997, it appeared that overweight fluctuated around 30%, and obesity prevalence increased steadily at a rapid pace. The increase was even steeper in the youngest age groups and for severe and complex obesity. Given the slightly different methodologies between the 1997–2012 studies and the 2020 survey, the worrying trends in obesity prevalence since 1997 must be confirmed, calling for a reedition of the Obepi-Roche series. Lire l'article complet sur : www.mdpi.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 22, 2023 10:26 AM
|
Les laboratoires pharmaceutiques à l'origine des vaccins contre la COVID-19 auraient expressément demandé au réseau social Twitter de réduire au silence les activistes qui appelaient au partage des brevets avec le reste du monde. Lire l'article complet sur : www.clubic.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 22, 2023 10:21 AM
|
Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated to have long COVID, with cases increasing daily. Biomedical research has made substantial progress in identifying various pathophysiological changes and risk factors and in characterizing the illness; further, similarities with other viral-onset illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome have laid the groundwork for research in the field. In this Review, we explore the current literature and highlight key findings, the overlap with other conditions, the variable onset of symptoms, long COVID in children and the impact of vaccinations. Although these key findings are critical to understanding long COVID, current diagnostic and treatment options are insufficient, and clinical trials must be prioritized that address leading hypotheses. Additionally, to strengthen long COVID research, future studies must account for biases and SARS-CoV-2 testing issues, build on viral-onset research, be inclusive of marginalized populations and meaningfully engage patients throughout the research process. Long COVID is an often debilitating illness of severe symptoms that can develop during or following COVID-19. In this Review, Davis, McCorkell, Vogel and Topol explore our knowledge of long COVID and highlight key findings, including potential mechanisms, the overlap with other conditions and potential treatments. They also discuss challenges and recommendations for long COVID research and care. Lire l'article complet sur : www.nature.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
December 8, 2022 2:44 AM
|
Dans un rapport publié mardi 6 décembre, la Cour des comptes pointe du doigt “l’efficacité incertaine” du contact tracing mis en place...-Santé Lire l'article complet sur : www.usine-digitale.fr
|
|
Scooped by
Lionel Reichardt / le Pharmageek
December 5, 2022 1:45 AM
|
Visible is a new activity-tracking platform designed to help those suffering from Long COVID track and manage their symptoms. Lire l'article complet sur : techcrunch.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
November 4, 2022 7:07 AM
|
Two views on the pigmentation dependence of pulse oximetry. Lire l'article complet sur : www.nature.com
|
|
Scooped by
Lionel Reichardt / le Pharmageek
November 3, 2022 2:27 AM
|
Annoncé en décembre 2020 à grand renfort de superlatifs, le projet Prédict-Est, présenté comme un « outil d’aide à la décision » destiné aux politiques, n’a pas vraiment tenu ses promesses de prédiction de l’évolution de l’épidémie de Covid. Lire l'article complet sur : www.dna.fr
|
Scoop.it!
